AI-generated summary
The authors pooled eleven randomized controlled trials of photobiomodulation in people with age-related cognitive impairment. They report a moderate, statistically significant improvement in global cognitive function, with effects differing by wavelength, light source, setting and cumulative irradiation time. The authors note that the included trials varied in design, which limits how firmly these findings can be interpreted.
- Studies included
- 11
- Who or what was studied
- People with age-related cognitive impairment
- Limits stated in the abstract
- The abstract does not report the number of participants and notes that the pooled effects are based on a small set of trials with variable parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Wavelength, Light-emitting diode, Risk of bias, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.